Pronađeno: 1-3 / 3 radova

Autori: Masliak Zvenyslava

>> Filter: Samo Article i Review

Naslov Pre-treated CML Patients in chronic phase (CP) not achieving at least a major cytogenetic remission (MCyR) after imatinib high dose (HD) induction (800 mg/day, 6 months) are at high risk of progression after dose reduction - Sub-analyses from the CELSG phase III "ISTAHIT" trial (Meeting Abstract)
Autori Petzer Andreas L  Fong Dominic  Lion Thomas  Dyagil Irina  Masliak Zvenyslava  Bogdanovic Andrija D  Griskevicius Laimonas  Lejniece Sandra  Goranov Stefan  Gercheva Liana  Stojanovic Aleksandar  Peytchev Dontcho  Tzvetkov Nikolay  Griniute Rasa  Oucheva Radka  Grubinger T  Kwakkelstein Marthin  Rancati Francesca  Gastl Guenther A  Wolf Dominik 
Info ONKOLOGIE, (2011), vol. 34 br. , Suppl. 6, str. 264-264
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study (Article)
Autori Petzer Andreas L  Wolf Dominik  Fong Dominic  Lion Thomas  Dyagil Irina  Masliak Zvenyslava  Bogdanovic Andrija D  Griskevicius Laimonas  Lejniece Sandra  Goranov Stefan  Gercheva Liana  Stojanovic Aleksandar  Peytchev Dontcho  Tzvetkov Nikolay  Griniute Rasa  Oucheva Radka  Ulmer Hanno  Kwakkelstein Marthin  Rancati Francesca  Gastl Guenther A 
Info HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, (2010), vol. 95 br. 6, str. 908-913
Projekat Novartis
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science   Scopus  
Naslov Multicenter, randomized, phase III study comparing imatinib (Glivec) standard dose (400 mg/d) with imatinib high dose induction (800 mg/d) followed by imatinib maintenance (400 mg/d) in patients with pretreated Ph+/BCR-ABL(+) CML in chronic phase - Results from the first planned interim analysis (CELSG-CML 11 ISTAHIT study) (Meeting Abstract)
Autori Petzer Andreas L  Wolf Dominik  Fong Dominic  Lion Thomas  Dyagil Irina  Masliak Zvenyslava  Boskovic Darinka V  Griskevicius Laimonas  Lejniece Sandra  Spasov Emil  Gercheva Liana  Stojanovic Aleksandar  Peytchev Dontcho  Tzvetkov Nikolay  Griniute Rasa  Stanchev Atanas  Kwakkelstein Martin  Ulmer Hanno  Gastl Guenther A 
Info BLOOD, (2007), vol. 110 br. 11, str. 317A-317A
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Ispis zapisa u formatu:TXT | BibTeX